These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19172857)

  • 41. En route to deoxygenated N-acetyllactosamine analogues employing uridyl and galactosyl transferases.
    Lazarevic D; Streicher H; Thiem J
    Carbohydr Res; 2009 Aug; 344(12):1449-52. PubMed ID: 19560126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of nucleotide derivatives and sugar nucleotide analogs as inhibitors of glycosyltransferases.
    Osumi K; Kawauchi N; Lu AH; Hindsgaul O; Palcic MM
    Nucleic Acids Symp Ser; 2000; (44):89-90. PubMed ID: 12903282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist.
    Davood A; Nematollahi AR; Iman M; Shafiee A
    Arch Pharm Res; 2009 Apr; 32(4):481-7. PubMed ID: 19407963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification of the sugar moiety in uridine via 2',3'-epoxyuridine derivatives.
    Takasu H; Tsuji Y; Sajiki H; Hirota K
    Nucleic Acids Symp Ser (Oxf); 2004; (48):49-50. PubMed ID: 17150472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of Mg2+ on the binding modes of HIV-1 integrase with thiazolothiazepine inhibitor studied by molecular simulation.
    Wang L
    Comput Biol Med; 2009 Apr; 39(4):355-60. PubMed ID: 19268284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modelling beta-1,3-exoglucanase-saccharide interactions: structure of the enzyme-substrate complex and enzyme binding to the cell wall.
    Moura-Tamames SA; Ramos MJ; Fernandes PA
    J Mol Graph Model; 2009; 27(8):908-20. PubMed ID: 19394255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some electrochemical characteristics of synthetic analogs of nucleic acid components. II. Derivatives of uridine and arabinosyluracil. An attempt to find correlation between some of their properties.
    Vachálková A; Novotný L
    Neoplasma; 1990; 37(5):555-63. PubMed ID: 2234216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Docking studies on DNA-ligand interactions: building and application of a protocol to identify the binding mode.
    Ricci CG; Netz PA
    J Chem Inf Model; 2009 Aug; 49(8):1925-35. PubMed ID: 19655805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probing replacement of pyrophosphate via click chemistry; synthesis of UDP-sugar analogues as potential glycosyl transferase inhibitors.
    Yeoh KK; Butters TD; Wilkinson BL; Fairbanks AJ
    Carbohydr Res; 2009 Mar; 344(5):586-91. PubMed ID: 19233348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting multiple ligand binding modes using self-consistent pharmacophore hypotheses.
    Wallach I; Lilien R
    J Chem Inf Model; 2009 Sep; 49(9):2116-28. PubMed ID: 19711952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bidirectional N-acetylglucosamine transfer mediated by beta-1,4-N-acetylglucosaminyltransferase III.
    Okada T; Ihara H; Ito R; Taniguchi N; Ikeda Y
    Glycobiology; 2009 Apr; 19(4):368-74. PubMed ID: 19095698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioactive conformation analysis of cyclic imides as protoporphyrinogen oxidase inhibitor by combining DFT calculations, QSAR and molecular dynamic simulations.
    Zhang L; Hao GF; Tan Y; Xi Z; Huang MZ; Yang GF
    Bioorg Med Chem; 2009 Jul; 17(14):4935-42. PubMed ID: 19540767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies.
    Raffa D; Maggio B; Cascioferro S; Raimondi MV; Daidone G; Plescia S; Schillaci D; Cusimano MG; Titone L; Colomba C; Tolomeo M
    Arch Pharm (Weinheim); 2009 May; 342(5):265-73. PubMed ID: 19415659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Managing protein flexibility in docking and its applications.
    B-Rao C; Subramanian J; Sharma SD
    Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
    De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
    ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects.
    Khan MT
    N Biotechnol; 2009 Jun; 25(5):331-46. PubMed ID: 19491049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adducts of uridine and glycals as potential substrates for glycosyltransferases.
    Wandzik I; Bieg T
    Bioorg Chem; 2007 Oct; 35(5):401-16. PubMed ID: 17707879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conserved cysteine residues of GidA are essential for biogenesis of 5-carboxymethylaminomethyluridine at tRNA anticodon.
    Osawa T; Ito K; Inanaga H; Nureki O; Tomita K; Numata T
    Structure; 2009 May; 17(5):713-24. PubMed ID: 19446527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elastic potential grids: accurate and efficient representation of intermolecular interactions for fully flexible docking.
    Kazemi S; Krüger DM; Sirockin F; Gohlke H
    ChemMedChem; 2009 Aug; 4(8):1264-8. PubMed ID: 19514026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.